Tuberculosis and Respiratory Diseases

Search

Page Path

HOME
Search

Case Reports

A Case of Anaphylaxis after the Treatment with Etoposide in a Patient with Small Cell Lung Cancer.: Young Il Kim, Kyu Sik Kim, Eui Ryoung Han, Yong Soo Kwan, In Jae Oh, Sung Chul Lim, Young Chul Kim; Tuberc Respir Dis. 2009;67(2):145-147. Published online August 1, 2009; DOI: https://doi.org/10.4046/trd.2009.67.2.145
Crossref 1; PDF

Original Articles

Clinical Response to Etoposide Plus Carboplatin and Topotecan Chemotherapy in Small Cell Lung Cancer.: Kyung Hwa Park, Gye Jung Cho, Jin Young Ju, Chang Young Son, Jeong Ook Wi, Kyu Sik Kim, Yu Il Kim, Sung Chul Lim, Young Chul Kim, Kyung Ok Park; Tuberc Respir Dis. 2003;54(4):415-428. Published online April 1, 2003; DOI: https://doi.org/10.4046/trd.2003.54.4.415; PDF

Clinical Efficacy of Combination Chemotherapy with Ifosfamide Cisplatin, and Etoposide(ICE) in Advanced Non-Small Cell Lung Cancer.: Gu Lee, Byung Duk Kim, Hee Jung Kang, Sang Won Lee, Hyun A Oh, Sung Hwa Bae, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Kyeong Cheol Shin, Jin Hong Jung, Kwan Ho Lee, Hun Mo Ryu; Tuberc Respir Dis. 2002;52(4):309-316. Published online April 1, 2002; DOI: https://doi.org/10.4046/trd.2002.52.4.309; PDF

A Phase II Trial of Combination Chemotherapy with Cisplatin & Etoposide in Small Cell Lung Cancer.: Eun Mee Cheon, Hyung Gun Kim, Tae Young Son, Young Jin Yuh, Sang Goo Lee, Choon Taek Lee, Young Hwan Kim, Jhin Oh Lee, Tae Woong Kang; Tuberc Respir Dis. 1994;41(6):632-643. Published online December 1, 1994; DOI: https://doi.org/10.4046/trd.1994.41.6.632; PDF

High VPP combination chemotherapy for advanced non-small cell lung cancer.: Seok Cheol Hong, Pyo Seong Han, Jong Jin Lee, Hai Jeong Cho, Ju Ock Kim, Sun Young Kim; Tuberc Respir Dis. 1993;40(4):367-377. Published online August 1, 1993; DOI: https://doi.org/10.4046/trd.1993.40.4.367
Crossref 1; PDF

Volume 87, No. 2

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

Impact Factor

2.9

MOST VIEWED MOST CITED

9,553	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
4,372	Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
2,554	Early Mobilization and Rehabilitation of Critically-Ill Patients
14,787	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
2,326	Association between Antacid Exposure and Risk of Interstitial Lung Diseases

Cited By 26	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 14	Tuberculosis: Republic of Korea, 2021
Cited By 12	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 10	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Cited By 10	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

prev

next